LXRX
Lexicon Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
LXRX Filings
Filing Date
Form Description
Form Type
2026-02-06
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-02-06 ·
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-02-02
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-02-02 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-02-02
Form 8-K - Current report
Key Events
2026-02-02 · Key Events
Form 8-K - Current report
2026-02-02
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-02 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-30
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-01-30 ·
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-01-30
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-01-30 ·
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-01-29
Form 8-K - Current report
Key Events
2026-01-29 · Key Events
Form 8-K - Current report
2026-01-29
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-29 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-10
Form 8-K - Current report
Key Events
2025-11-10 · Key Events
Form 8-K - Current report
2025-11-06
Lexicon Pharmaceuticals, Inc. (LXRX) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-06 · Earnings Call
Lexicon Pharmaceuticals, Inc. (LXRX) Q3 2025 Earnings Call Transcript
